Genome Medical is breaking down barriers to genetic testing access for people with a rare condition that has for too long baffled the medical community.
Through a new partnership with the Hereditary Neuropathy Foundation (HNF) and Tara A. Jones MS, LCGC, at Cedars-Sinai Medical Center, we are supporting the CMT Genie Project, a strategic genetic testing program that will provide faster and more equitable access to critical genetic care for the Charcot-Marie-Tooth (CMT) community and its health care providers.
CMT is an inherited, progressive condition that occurs when mutations in the genes affect the nerves in the feet, legs, hands and arms.
Through the CMT Genie Project, a Genome Medical genetic counselor will provide initial telehealth consultations with patients to discuss their health history and testing options. Genetic tests may be ordered, followed by a virtual appointment to review and understand the test results and get recommendations for additional care if needed.
“The CMT Genie Project is just the sort of initiative Genome Medical was founded to support,” says Steven Bleyl, MD, PhD, medical geneticist and chief medical officer with Genome Medical. “We are proud to be part of the solution to the care gaps that individuals with hereditary neuropathies face, and we are excited to bring the advancements of genomic technology to the patients through our national network of genetic counselors and physicians.”
